What Do We Offer?
FutuRx provides a unique model for supporting early stage innovation, by combining expertise of FutuRx management team, and global capabilities of the founders – Johnson & Johnson Innovation – JJDC, Takeda Ventures Inc.- TVI and OrbiMed Israel Partners teamed with the The Technological Incubators Program at the Israeli Innovation Authority.
As the incubator is based on international cooperation, companies established by FutuRx benefit from professional assistance by industry leading experts. These global capabilities facilitate the development of innovative technologies, on the way to safely turning them into cutting-edge products for the benefit of patients and healthcare providers.
Each new project company established in FutuRx enjoys robust support to maximize chances of success:
1200sqm facility includes offices and fully equipped laboratories with space for more than 10 project companies
Mentoring and Guidance
Access to expertise of FutuRx and its global founders in drug-development, industry-standard laboratory practices and project-management
Operational and administrative support
Finance & accounting, Intellectual Property strategy, legal, IT, admin and HR
Access to potential collaborators and investors, leading experts, clinical and regulatory consultants as well as service providers
Incubation for 3 years
With a base $2.1M budget of which up to 85% from OCS, support through OCS applications and reporting
Support for follow-on funding rounds
Exposing companies to relevant investors through focused business development efforts, high quality presentations and compilation of product files